Harvard Bioscience (HBIO) EBT Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 26.74% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -2.64% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -123.12% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 3.52% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -34.54% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 14.71% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 4.85% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -133.49% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 18.80% |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | -28.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -28.48% |
| Mar 31, 2026 | 93.49% |
| Dec 31, 2025 | -643.05% |
| Sep 30, 2025 | 74.75% |
| Jun 30, 2025 | 31.28% |
| Mar 31, 2025 | -1,032.78% |
| Dec 31, 2024 | 153.49% |
| Sep 30, 2024 | -699.11% |
| Jun 30, 2024 | -56.34% |
| Mar 31, 2024 | -471.50% |
| Dec 31, 2023 | -23.65% |
| Sep 30, 2023 | 88.02% |
| Jun 30, 2023 | -161.33% |
| Mar 31, 2023 | 117.20% |
| Dec 31, 2022 | -178.87% |
| Sep 30, 2022 | -10,522.22% |
| Jun 30, 2022 | 641.30% |
| Mar 31, 2022 | -926.02% |
| Dec 31, 2021 | 306.39% |
| Sep 30, 2021 | 103.18% |